Navigation Links
Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin
Date:9/17/2012

September 17, 2012 (BRONX, NY) The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded nearly $11 million to Albert Einstein College of Medicine of Yeshiva University to carry out a five-year multi-institutional study of hemoglobin toxicity that may complicate blood transfusions and reduce the effectiveness of blood substitutes. The long-term goals include making blood transfusions safer and more effective and better matching patients with the transfusion strategy best suited to them.

The research is especially important due to the explosion of obesity, diabetes and metabolic syndrome, which increases inflammation in blood vessels and can lead to transfusion complications.

The $10.8 million program project grant will be overseen by the principle investigator, Einstein's Joel Friedman, M.D., Ph.D. , who holds the Young Men's Division Chair in Physiology and is professor of physiology & biophysics and of medicine. The grant will fund research projects at Einstein, Rice University, the University of California, San Diego and the United States Food and Drug Administration (FDA), directed by Dr. Friedman, John Olson, Ph.D., Marcos Intaglietta, Ph.D., and Abdu Alayash, Ph.D., respectively.

The grant focuses on the study of hemoglobin, the protein that gives red blood cells their color. Red cells transport oxygen throughout the body and deliver it to cells. Hemoglobin normally stays inside red blood cells. But under some conditionsincluding sickle cell anemia and transfusions involving stored bloodred cells break open, or lyse, causing substantial amounts of hemoglobin to become acel
'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers find our inner reptile hearts
2. Researchers develop rapid method to measure carbon footprints
3. Rockefeller Universitys Pearl Meister Greengard Prize to be awarded to RNA researcher Joan Steitz
4. Researchers reveal a chemo-resistant cancer stem cell as cancers Achilles heel
5. Researchers use banker plants to help battle whitefly pests
6. Researchers find first evidence for a genetic cause for Barretts oesophagus
7. CIRM funds 6 UC San Diego stem cell researchers
8. Rice University researchers optimize photoluminescent probes to study DNA and more
9. Researchers identify biochemical functions for most of the human genome
10. Georgetown Lombardi researcher awarded Provocative Question grant from NCI
11. NIH-funded researchers restore sense of smell in mice using genetic technique
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... domestic heating may contribute to early fetal death according ... Research Institute of Children,s Hospital Los Angeles and Ulaanbaatar, ... , In a paper published today in the journal ... strong statistical correlations" between seasonal ambient air pollutants and ... has one of the highest levels of air pollution ...
(Date:4/23/2014)... hungry diner ripping open a dinner roll, a fuel ... open a hydrogen molecule. Now researchers have captured a ... halves of its hydrogen feast. The view confirms previous ... catalyst work better for alternative energy uses. , This ... where the hydrogen halves end up in the structure ...
(Date:4/23/2014)... shows that male black widow spiders prefer their female ... of mate preference by male spiders. , ... Maydianne Andrade, a professor in UTSC,s Department of Biological ... wild that males overwhelmingly chose to mate with well-fed, ... tell whether a potential mate is well-fed and unmated ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Picky male black widow spiders prefer well-fed virgins 2
... research team has tested the utility of the short version ... disability in patients with depression, "which in the case of ... of the instrument." In Spain, more than 10% of ... is usually the first to screen an individual who feels ...
... today by ESA,s Envisat satellite, shows the vast cloud of ... Iceland, more than 1000 km away. Carried by winds ... the eruption of the Eyjafjallajoekull glacier in southwest Iceland has ... Scandinavia, with further disruption in northern Europe expected later today. ...
... This press release is available in French . ... of the 20th century, but new research shows initiatives of ... dollars as people might think. McGill University Biologist Dr. Jonathan ... most affected by them is a far more effective and ...
Cached Biology News:It takes only 5 minutes to assess disability in patients with depression 2Trying to eradicate a disease is a waste of money: researcher 2
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... Jan. 14, 2014 As pet owners drew up their lists ... them wrote: "Take better care of my furry companion." Nowadays there ... and top-brand carrying cases to take the little canine or feline ... feel compelled to buy some pricey toys at the pet store. ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... 2014 Kerr Corporation, a leading manufacturer of ... how-to information about dual arch impressions on its dental blog. ... Impressions,” the blog entry serves up a list of tips ... step-by-step demonstration by Dr. David Little as he crafts a ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... This release is available in German . ... from the physics department at the TUM discovered an entirely ... grid of magnetic eddies. Together with the team of Professor ... properties of these eddies, so-called skyrmions, named after the British ...
... Calif., Feb. 21, 2012 Onyx Pharmaceuticals, Inc. (Nasdaq: ... conferences in February and March. 2012 Citi Global ... Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern ... Company 32nd Annual Health Care Conference Onyx will present at ...
... 21, 2012  Wake Forest Baptist Medical Center has ... a new state-of-the-art, world-class 242,000 square foot biotechnology ... growth of Wake Forest Baptist,s many renowned research ... companies generated by researchers, discoveries and space for ...
Cached Biology Technology:Saving data in vortex structures 2Onyx Pharmaceuticals to Present at Upcoming Investor Conferences 2Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 2Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 3Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 4